Table 1 General clinical and echocardiographic characteristics of the subjects
Male gender (n /%) | 84/41.2 |
Age (years) | 60.2 ± 10.2 |
Current smoker (n /%) | 59/28.9 |
Hypertension (n /%) | 133/65.2 |
Diabetes mellitus (n /%) | 38/18.6 |
Obese (n /%) | 38/18.6 |
Hypercholesterolemia (n /%) | 52/25.5 |
Statin use (n /%) | 163/79.9 |
Other lipid regulator use (n /%) | 30/14.7 |
ACE inhibitor use (n /%) | 92/45.1 |
β blocker use (n /%) | 103/50.5 |
Heart rate (beats/min) | 78.1 ± 13.4 |
Systolic blood pressure (mmHg) | 141.8 ± 22.8 |
Diastolic blood pressure (mmHg) | 83.1 ± 15.3 |
Body mass index (kg/m2) | 25.2 ± 2.9 |
Fasting plasma glucose (mmol/L) | 5.89 ± 1.88 |
Hemoglobin A1C (%) | 6.09 ± 1.11 |
Total cholesterol (mmol/L) | 4.75 ± 1.05 |
Low-density lipoprotein cholesterol (mmol/L) | 3.03 ± 0.89 |
High-density lipoprotein cholesterol (mmol/L) | 1.14 ± 0.29 |
Triglyceride (mmol/L) | 1.78 ± 1.42 |
Uric acid (umol/L) | 309.3 ± 77.4 |
Cystatin C (mg/L) | 0.83 ± 0.19 |
High-sensitive C-reactive protein (mg/L) | 1.54 ± 1.60 |
LA (mm) | 35.5 ± 3.8 |
LVDD (mm) | 47.1 ± 3.5 |
IVS (mm) | 9.3 ± 1.5 |
PD (mm) | 8.8 ± 1.1 |
e’ (cm/s) | 7.09 ± 1.97 |
E/e’ | 11.24 ± 3.10 |
E/A | 0.88 ± 0.29 |
LVEF (%) | 63.87 ± 3.97 |